Veriheal

MAY 3, 2022

The study was conducted by more than 10 researchers, with leads Dr. Jodi Gilman and Dr. Kevin Potter taking responsibility for the integrity and accuracy of the data. Clinical Trial Sample Size. Does the Data Justify the Conclusions? Investigating the Impact of MMJ Cards. Daily Cannabis Use as a Disqualifier.

Research and Development 98

Research and Development Clinical Trials Consumption Patients 98

Cannabis Law Report

AUGUST 2, 2021

The nearly 3,000 participant study will capture and publish the most comprehensive data ever collected on CBD product effectiveness from 13 commercially available U.S. Radicle ACES is Institutional Review Board (IRB) approved and will capture CBD effectiveness data directly from nearly 3,000 study participants.

CBD 105

CBD Data Sleep Clinical Trials 105

SpeedWeed

AUGUST 11, 2021

This will be the second clinical trial to give cannabis medicine or placebos to participating military veterans, and according to the Chief Science Officer of the MAPS Public Benefit Corporation, Berra Yazar-Klosinki, PhD, the first trial was a great success. “We View original article. MAPS Makes History.

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical DEA 52

SpeedWeed

MAY 22, 2021

The US Food and Drug Administration (FDA) has just approved a new clinical trial that will allow therapists to legally use MDMA. For this Phase 1 trial, MAPS will recruit 150 therapists that are currently being trained to conduct MDMA-assisted therapy sessions for PTSD. . View original article.

Clinical Trials 52

Clinical Trials Therapy Legalization Research and Development 52

SpeedWeed

SEPTEMBER 17, 2021

Data collected from MAPS-sponsored Phase 3 clinical trials suggests that MDMA-assisted therapy appears promising in the treatment of TBI. Adapt MAPS’ equitable access research projects to develop a meaningful patient access program. View original article. Beyond MDMA, MAPS Pushes Psychedelic Research Forward.

Clinical Trials 53

Clinical Trials Research and Development Therapy Treatment 53

SpeedWeed

MARCH 26, 2021

This excessive inflammation, commonly known as a “cytokine storm,” is one of the leading causes of death in patients hospitalized with COVID. . For this test, the researchers used data from 93,000 patients who had taken COVID tests at the University of Chicago Medical Center. View original article.

CBD 52

CBD Clinical Trials Cannabinoids Patients 52

The Cannigma

JULY 1, 2022

There’s no doubt that the amount of information that is available about cannabis is at an all-time high – in 2020 alone, over 3,500 scientific articles were published on the topic. Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Healer

MARCH 26, 2021

This article was originally published in the Portland Press Herald. Gresh has joined a growing number of patients who swear by medical cannabis not only as a treatment option for chronic pain, but also as a substitute for prescription opioids used in pain management. March 19, 2021. Others aren’t so sure.

Chronic Pain 86

Chronic Pain Clinical Trials Treatment Patients 86

Cannabis Law Report

DECEMBER 7, 2021

Scientific Reports volume 11 , Article number: 23462 ( 2021 ) Cite this article. However, despite the increased use of MCs in children, there is limited data regarding their safety and efficacy in this population for those different indications 11. Data extraction. Stolar & Ilan Matok. Metrics details.

Safety 52

Safety Cannabinoids Events Data 52

Cannabis Law Report

JULY 6, 2021

Bankole Johnson was featured in a March 5 th 2021 Forbes article, “Dr. Johnson, DSc, MD, MPhil, FRCPsych said, “I am pleased to join the Ehave Medical Advisory Board and look forward to working towards bringing psychedelic-assisted therapies to patients experiencing substance use issues. ” About Ehave, Inc. Ehave, Inc.

Research and Development 97

Research and Development Wellness and Beauty Clinical Trials Therapy 97

Cannabis Law Report

MAY 14, 2022

In addition to the regulatory barriers to access, funding has long been cited as a problem, with limited patient access through the UK’s National Health Service. Canpain is planned to run for three years and aims to conduct clinical trials involving up to 5,000 patients suffering from chronic pain.

Access 52

Access CBD Research and Development Medicine 52

The Joint Blog

FEBRUARY 24, 2021

Though trialing is relatively new and there is no clear scientific evidence as of yet, anecdotal evidence from patients is looking positive. The effects were so promising that Parkinson’s UK began funding for the worlds first clinical trial. This trial was to take 3.5 Out of these respondents, 45.9%

Treatment 55

Treatment Clinical Trials Collective Patients 55

The Joint Blog

APRIL 17, 2020

Medical cannabis is typically prescribed for patients with severe conditions including inflammatory conditions (e.g., Additionally, there are variations based on the patients at a physiology, route of administration, and administration practices level. In 2018, ProCon.org has estimated well over 3.5M

Events 48

Events THC Chronic Pain Sleep 48

Cannabis Law Report

DECEMBER 21, 2021

The rapid increase in the volume of enterprise data and growing automation of business processes across several end-use industries such as retail, manufacturing, healthcare, and transportation are expected to drive the demand for business software and services over the forecast period. billion in 2020 (Grandview Research). from 2021 to 2028.

Research and Development 52

Research and Development Supply Chain Data Business 52

SpeedWeed

FEBRUARY 18, 2021

The study was carried out by researchers in Israel, who looked at how inhaling herbal cannabis impacted ulcerative colitis patients over a period of eight weeks, with continued, steady, use. The patients also kept taking standard medication. The patients also kept taking standard medication. View original article.

Clinical Trials 52

Clinical Trials Treatment Data THC 52

The Cannigma

JUNE 15, 2021

Some healthcare professionals are already encouraged by what is known, much of it anecdotal accounts from patients in their practices. The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Project CBD

FEBRUARY 27, 2023

Instead, patients turn to a mix of whatever individual medications, therapies, and lifestyle changes (especially exercise) help ease symptoms and improve quality of life. “Available data strongly support the use of cannabinoids in treating fibromyalgia pain” due to “overwhelmingly positive treatment results.” It’s not a new idea.

THC 144

THC CBD Sleep Clinical Trials 144

The Cannigma

JANUARY 13, 2023

This article includes strain names as a starting point for you to find flower or products near you that match the chemical makeup, not the exact strain name. Like many conditions that modern medicine falls short of treating, migraines are now suspected to be a possible problem of endocannabinoid system deficiency in some patients.

Terpenes 132

Terpenes Strains THC Treatment 132

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. Available at: www.ncbi.nlm.nih.gov/pmc/articles/PMC7400098/.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

NOVEMBER 29, 2021

18 articles. Treatment-resistant depression – meaning patients have tried everything possible and did not find relief – is a harrowing condition affecting one in three people with depression – that’s a staggering one hundred million people worldwide for whom current depression treatments just don’t work. Christian Angermayer.

Treatment 52

Treatment Clinical Trials Data Patients 52

The Joint Blog

APRIL 21, 2020

For the study researchers with the Nordic Cannabis Research Institute in Denmark reviewed 25 clinical trials assessing the safety and efficacy of CBD in various populations. There is moderate-quality evidence that chronic and acute administration of CBD can improve psychotic symptoms in schizophrenia patients.”

Clinical Trials 52

Clinical Trials CBD Safety Patients 52

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. A total of 117 articles were retrieved for analysis, the majority of which were news stories for a physician audience.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

JULY 12, 2019

Access is clearly in demand from Londoners as there is already a waiting list of 150 patients at the London clinic ahead of its opening. Why aren’t more patients in need able to access medicinal cannabis via the NHS, and will this improve? Background to the legalisation of medical cannabis in the UK.

Epilepsy 40

Epilepsy Medicine Clinical Trials Chronic Pain 40

The Cannigma

APRIL 8, 2021

We passed each other in Zoom meetings, reviewed some of my articles that I’ve written with The Cannigma. MSO: You’re a pharmacist, you’re a clinical pharmacist. So yeah, I spend my time helping physicians and nurses more than I do counting bills and talking to patients. CP: I mean, pick away. But yeah, I totally agree.

Medicine 108

Medicine Cannabinoids Cannabis THC 108

Cannabis Law Report

NOVEMBER 26, 2021

Corporate and Clinical Development Highlights Include: Completed Patient Enrollment in Phase III Psoriasis Study – The Phase III Comfort™ study completed patient enrollment. dollars in thousands (except for share and per share data). . . Topline results are expected in Q1 2022. Financial Results. 2021. . .

Clinical Trials 52

Clinical Trials Research and Development Treatment Data 52

Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. MAPS continued to publish Bulletin articles about MDMA research , requests for donations , and discontinuing animal studies.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Cannabis Law Report

MAY 13, 2019

Medical professionals want more information about medicinal cannabis before they start prescribing it to patients, a new study has found. Screening for relevancy, full-text review, data extraction, and risk of bias were completed by two independent investigators. Pre-defined inclusion and exclusion criteria were applied uniformly.

Medicine 45

Medicine Research and Development Clinical Trials Data 45

CannaMD

OCTOBER 7, 2019

Besides going against all the classic “munchies/stoner” stereotypes, this finding is especially puzzling as cannabis is often used to increase weight gain in patients with medical conditions such as HIV/AIDS and cancer. So why are medical marijuana patients gaining weight when they need to, but losing weight when they don’t?

Marijuana 105

Marijuana Cannabinoids Patients Conditions 105

Green Relief

MAY 13, 2018

A 2014 study found that traumatic brain injury ( TBI ) patients who tested positive for THC were more likely to survive with less impairment than TBI patients who abstained from marijuana. As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury.

THC 64

THC CBD Cannabinoids Research and Development 64

Alchimia

JANUARY 25, 2022

These articles reported the findings of a study by Oregon State University into the effect that cannabis has on the cellular pathways that the COVID virus (an acronym for coronavirus disease) uses to invade the body. The Oregon State University study that has gone viral (pun intended). THC is also no stranger to the fight. Pain relief.

Research and Development 98

Research and Development Terpenes CBD Treatment 98

SMPL

MAY 26, 2020

Miller spent the months after this meeting leading hundreds of CBD seminars for farmers; Dr. Kerr began informal patient surveys to track how CBD made people feel; and as he finished his book, Mr. Lee often traveled around with Mr. Laughter and Mr. Ringo’s high-CBD plants and seeds, spreading the gospel at pot shops across the West.

CBD 40

CBD Research and Development Pharmaceutical Seed-To-Sale 40

Green Relief

MAY 12, 2018

A 2014 study found that traumatic brain injury ( TBI ) patients who tested positive for THC were more likely to survive with less impairment than TBI patients who abstained from marijuana. As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury.

Research and Development 40

Research and Development Cannabinoids Therapy CBD 40

Cannabis Law Report

OCTOBER 29, 2019

The PK data on cats shows there are differences in absorption between cats and dogs and that dosing may be different between these two species and that our chew form is likely to be more absorbable than oils in general. This data gives us confidence in the use of both the chew and the oils as effective means for delivering CBD to your pet.”.

Safety 45

Safety CBD Clinical Trials Oil 45

Freedom Leaf

JANUARY 10, 2018

“We’re actively working toward developing new genetics to work on efficacy and assist the patients in Israel still operating with our nurse-run clinics in order to better provide the right dosage and strains for the patients who are referred to us by the Ministry of Health,” Stephen Gardner, Tikun Olam’s chief marketing officer, tells Freedom Leaf.

Research and Development 49

Research and Development Clinical Trials Strains Patients 49

Cannabis Law Report

DECEMBER 7, 2021

“Despite the massive and growing market size, there is still scant data on the effectiveness of over-the-counter cannabinoid products due to the cost, speed and scale limitations of the current approach to scientific research,” said Jeff Chen, MD/MBA, Co-founder and CEO of Radicle Science. in less than four days.

Clinical Trials 52

Clinical Trials CBD Data Sleep 52

Cannabis Law Report

JUNE 4, 2021

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. She is author, co-author, and co-editor of twenty-two books, two special-edition journals, and several peer-reviewed articles.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

Cannabis Law Report

OCTOBER 17, 2019

Another researcher, New Frontier Data, pegged the global value of legal and illicit cannabis together at $340 billion in 2018. It’s big business,” says Jackim, noting that there are 200,000 patients in the state who hold cards allowing them to purchase cannabis for medical purposes. billion in 2025, according to Grandview Research.

Law 40

Law Seed-To-Sale Hemp Recreational 40